2024
A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study
Vaughn J, Ramdhanny A, Munir M, Rimmalapudi S, Epperla N. A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study. Blood Cancer Journal 2024, 14: 212. PMID: 39609401, PMCID: PMC11604794, DOI: 10.1038/s41408-024-01194-5.Peer-Reviewed Original ResearchConceptsIndolent non-Hodgkin lymphomaLymphoma-specific survivalDe novo DLBCLOverall survivalIndolent lymphomaT-FLHistological transformationRelative survivalDe novo diffuse large B-cell lymphomaIndolent non-Hodgkin's lymphoma subtypesDiffuse large B-cell lymphomaReceipt of prior chemotherapyAssociated with inferior survivalLarge B-cell lymphomaMedian follow-up timeStudy of adult patientsLymphoplasmacytic lymphoma/Waldenstrom macroglobulinemiaTransformed indolent lymphomaMarginal zone lymphomaNon-Hodgkin's lymphomaB-cell lymphomaTransformed follicular lymphomaIncidence of HTPopulation-based cohort studyPopulation-based study
2021
Survival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017)
Vaughn J, Pinheiro L, Olszewski A, Epperla N. Survival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017). American Journal Of Hematology 2021, 96: e123-e126. PMID: 33476433, DOI: 10.1002/ajh.26103.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesConfounding Factors, EpidemiologicFemaleHumansKaplan-Meier EstimateLymphoma, B-Cell, Marginal ZoneMaleMiddle AgedMortalityPrognosisRituximabSEER ProgramSocial Determinants of HealthUnited StatesYoung Adult